Saratoga Research & Investment Management Novo Nordisk A S Transaction History
Saratoga Research & Investment Management
- $2.2 Billion
- Q2 2024
A detailed history of Saratoga Research & Investment Management transactions in Novo Nordisk A S stock. As of the latest transaction made, Saratoga Research & Investment Management holds 748,717 shares of NVO stock, worth $98 Million. This represents 4.86% of its overall portfolio holdings.
Number of Shares
748,717
Previous 783,791
4.47%
Holding current value
$98 Million
Previous $101 Million
6.19%
% of portfolio
4.86%
Previous 4.57%
Shares
28 transactions
Others Institutions Holding NVO
# of Institutions
1,988Shares Held
318MCall Options Held
5.23MPut Options Held
4.97M-
Jennison Associates LLC21.2MShares$2.78 Billion1.95% of portfolio
-
Morgan Stanley New York, NY14.6MShares$1.91 Billion0.16% of portfolio
-
Bank Of America Corp Charlotte, NC14.2MShares$1.86 Billion0.18% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa13.4MShares$1.75 Billion0.83% of portfolio
-
Fayez Sarofim & CO Houston, TX12.6MShares$1.64 Billion4.91% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $295B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...